Silk Road Medical, Inc
SILK
NASDAQ
| 06/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 5.69% | 2.57% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.69% | 2.57% | |||
| Cost of Revenue | 6.28% | -3.89% | |||
| Gross Profit | 5.49% | 4.88% | |||
| SG&A Expenses | 7.46% | 4.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.91% | 2.88% | |||
| Operating Income | -15.14% | -3.91% | |||
| Income Before Tax | -17.45% | -9.01% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -17.45% | -8.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -17.45% | -8.65% | |||
| EBIT | -15.14% | -3.91% | |||
| EBITDA | -15.68% | -4.18% | |||
| EPS Basic | -16.39% | -8.04% | |||
| Normalized Basic EPS | -16.40% | -8.54% | |||
| EPS Diluted | -16.39% | -8.04% | |||
| Normalized Diluted EPS | -16.40% | -8.54% | |||
| Average Basic Shares Outstanding | 0.92% | 0.54% | |||
| Average Diluted Shares Outstanding | 0.92% | 0.54% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
